A33 (Cefuroxime 250 mg)

Pill imprint A33 has been identified as Cefuroxime axetil 250 mg.

Cefuroxime is used in the treatment of bacterial infection; urinary tract infection; sinusitis; bronchitis; bladder infection (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefuroxime 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for A33

Cefuroxime axetil 250 mg A33
Cefuroxime axetil
Imprint:
A33
Strength:
250 mg
Color:
White
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Second generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Aurobindo Pharma Limited
National Drug Code (NDC):
65862-0034
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hydrogenated cottonseed oil
microcrystalline cellulose
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
59762-1081 Greenstone LLC
21695-0370 Rebel Distributors Corp (repackager)
53002-0275 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)